share_log

Waters Co. (NYSE:WAT) Shares Acquired by Bank of America Corp DE

Waters Co. (NYSE:WAT) Shares Acquired by Bank of America Corp DE

沃特斯公司(紐約證券交易所代碼:WAT)被美國銀行收購的股票
Defense World ·  2022/09/24 05:51

Bank of America Corp DE lifted its holdings in shares of Waters Co. (NYSE:WAT – Get Rating) by 2.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 347,839 shares of the medical instruments supplier's stock after acquiring an additional 7,729 shares during the quarter. Bank of America Corp DE owned about 0.58% of Waters worth $107,964,000 as of its most recent filing with the Securities and Exchange Commission.

美國銀行(Bank Of America Corp DE)最近向美國證券交易委員會(Securities And Exchange Commission)提交的13F文件顯示,該公司在第一季度增持了Waters Co.(紐約證券交易所代碼:WAT-GET)的股票2.3%。該機構投資者在本季度額外收購了7729股後,持有這家醫療器械供應商的347,839股股票。截至最近提交給美國證券交易委員會(Securities And Exchange Commission)的文件,美國銀行DE持有Waters約0.58%的股份,價值107,964,000美元。

Several other hedge funds and other institutional investors have also made changes to their positions in the business. MainStreet Investment Advisors LLC lifted its holdings in shares of Waters by 0.7% during the 1st quarter. MainStreet Investment Advisors LLC now owns 4,757 shares of the medical instruments supplier's stock valued at $1,476,000 after acquiring an additional 35 shares in the last quarter. Camden Capital LLC lifted its holdings in Waters by 3.3% in the 4th quarter. Camden Capital LLC now owns 1,122 shares of the medical instruments supplier's stock worth $418,000 after buying an additional 36 shares in the last quarter. FDx Advisors Inc. lifted its holdings in Waters by 5.0% in the 1st quarter. FDx Advisors Inc. now owns 776 shares of the medical instruments supplier's stock worth $241,000 after buying an additional 37 shares in the last quarter. Signaturefd LLC lifted its holdings in Waters by 6.1% in the 1st quarter. Signaturefd LLC now owns 660 shares of the medical instruments supplier's stock worth $205,000 after buying an additional 38 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its holdings in Waters by 0.9% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 4,556 shares of the medical instruments supplier's stock worth $1,414,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 88.80% of the company's stock.

其他幾家對衝基金和其他機構投資者也改變了他們在該業務中的頭寸。MainStreet Investment Advisors LLC在第一季度增持了0.7%的Waters股票。MainStreet Investment Advisors LLC現在擁有這家醫療器械供應商4,757股股票,價值1,476,000美元,上個季度又收購了35股。Camden Capital LLC在第四季度增持了3.3%的Waters股份。Camden Capital LLC現在擁有這家醫療器械供應商1,122股股票,價值418,000美元,上個季度又購買了36股。第一季度,FDX Advisors Inc.增持Waters股票5.0%。FDX Advisors Inc.現在持有這家醫療器械供應商776股股票,價值241,000美元,此前該公司在上個季度又購買了37股。Signaturefd LLC在第一季度增持了6.1%的Waters股份。Signaturefd LLC現在持有這家醫療器械供應商660股股票,價值20.5萬美元,上個季度又購買了38股。最後,MassMutual Trust Co.FSB ADV在第一季度增持了0.9%的Waters股份。MassMutual Trust Co.FSB ADV目前持有這家醫療器械供應商4,556股股票,價值1,414,000美元,此前該公司在上個季度又購買了40股。機構投資者和對衝基金持有該公司88.80%的股票。

Get
到達
Waters
水域
alerts:
警報:

Waters Price Performance

水域價格表現

Shares of NYSE:WAT opened at $275.50 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.10 and a debt-to-equity ratio of 3.66. Waters Co. has a fifty-two week low of $270.36 and a fifty-two week high of $399.81. The firm has a 50-day simple moving average of $319.36 and a 200 day simple moving average of $320.70. The company has a market cap of $16.50 billion, a PE ratio of 24.04, a P/E/G ratio of 3.05 and a beta of 0.87.

週五,紐約證交所:WAT的股價開盤報275.50美元。該公司的速動比率為1.55,流動比率為2.10,債務權益比為3.66。Waters Co.的股價為270.36美元,為52周低點,52周高點為399.81美元。該公司的50日簡單移動均線切入位在319.36美元,200日簡單移動均線切入位在320.70美元。該公司市值165億美元,市盈率24.04倍,市盈率3.05倍,貝塔係數0.87。

Waters (NYSE:WAT – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The business had revenue of $714.30 million during the quarter, compared to the consensus estimate of $706.77 million. During the same quarter in the prior year, the firm earned $2.60 EPS. The company's revenue for the quarter was up 4.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Waters Co. will post 12 EPS for the current year.
Waters(紐約證券交易所代碼:WAT-GET評級)上一次公佈季度收益數據是在8月2日星期二。這家醫療器械供應商公佈本季度每股收益為2.75美元,比分析師普遍預期的2.63美元高出0.12美元。Waters的淨利潤率為24.21%,股本回報率為203.31%。該業務本季度的收入為7.143億美元,而普遍預期為7.0677億美元。去年同期,該公司每股收益為2.60美元。與去年同期相比,該公司本季度的收入增長了4.8%。賣方分析師平均預計Waters Co.本年度每股收益將達到12歐元。

Analyst Ratings Changes

分析師評級發生變化

A number of equities analysts have commented on WAT shares. Credit Suisse Group started coverage on shares of Waters in a report on Wednesday, August 24th. They issued a "neutral" rating and a $345.00 price objective on the stock. UBS Group boosted their price objective on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, August 4th. Barclays dropped their target price on shares of Waters from $375.00 to $345.00 and set an "overweight" rating for the company in a research report on Monday, September 12th. Cowen boosted their target price on shares of Waters to $378.00 in a research report on Tuesday, August 9th. Finally, Robert W. Baird boosted their target price on shares of Waters from $340.00 to $348.00 in a research report on Wednesday, August 3rd. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $348.25.

許多股票分析師對Wat股票發表了評論。瑞士信貸集團在8月24日星期三的一份報告中開始報道Waters的股票。他們對該股給予了“中性”評級和345.00美元的目標價。瑞銀集團將Waters股票的目標價從349.00美元上調至375.00美元,並在8月4日週四的一份報告中給予該股“中性”評級。巴克萊將Waters股票的目標價從375.00美元下調至345.00美元,並在9月12日週一的一份研究報告中對該公司設定了“增持”評級。考恩在8月9日週二的一份研究報告中將Waters的目標股價上調至378.00美元。最後,羅伯特·W·貝爾德在8月3日星期三的一份研究報告中將Waters的目標股價從340.00美元上調至348.00美元。五名投資分析師對該股的評級為持有,兩名分析師對該公司股票的評級為買入。根據MarketBeat的數據,該公司的平均評級為“持有”,平均目標價為348.25美元。

Waters Profile

水域縱斷面

(Get Rating)

(獲取評級)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Waters Corporation是一家專業測量公司,在亞洲、美洲和歐洲提供分析工作流程解決方案。它通過兩個部門運營,Waters和TA。該公司設計、製造、銷售和服務高性能和超高性能液相色譜,以及質譜儀(MS)技術系統和支持產品,包括色譜柱、其他消耗品和保修後服務計劃。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Waters (WAT)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Will Crowdstrike Get A Boost From Increased EPS Guidance?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免費獲取StockNews.com關於Waters的研究報告(Wat)
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • CrowdStrike是否會從增加每股收益指引中獲得提振?
  • 好市多盈利後價格疲軟是買入的好時機嗎?
  • 需要關注的2只半導體類股走勢逆轉

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

接受《Waters Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Waters和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論